Find trials
Search tips

A Study of Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation

Overview

About this study

The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation and promote healthy behaviors in adults.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Had a 10-second 12-lead ECG done at Mayo Clinic.
  • Have a high AI-ECG risk score indicating a high likelihood of previously unrecognized atrial fibrilation (AF).
  • Men with CHA2DS2-VASc2 ≥ 2 or women with CHA2DS2-VASc ≥ 3.

Exclusion Criteria:

  • Diagnosed atrial fibrillation.
  • Diagnosed dementia.
  • Diagnosed end-stage kidney disease.
  • History of intracranial bleeding.
  • Have an implantable cardiac monitoring device, including a pacemaker, a defibrillator, or implanted loop recorder.
  • Missing date of birth.
  • Residence outside of the U.S. or missing address information.

Eligibility last updated 6/28/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Xiaoxi Yao, Ph.D., M.P.H.

Open for enrollment

Contact information:

Kayla Weber

(507) 538-6743

Couillard.Kayla@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20549580

Mayo Clinic Footer